BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21975787)

  • 1. Pharmacologic treatment for memory disorder in multiple sclerosis.
    He D; Zhou H; Guo D; Hao Z; Wu B
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008876. PubMed ID: 21975787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment for memory disorder in multiple sclerosis.
    He D; Zhang Y; Dong S; Wang D; Gao X; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008876. PubMed ID: 24343792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
    Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
    Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment for memory disorder in multiple sclerosis.
    Bellman S
    Int J Evid Based Healthc; 2017 Dec; 15(4):186-187. PubMed ID: 28937413
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological interventions for cognitive decline in people with Down syndrome.
    Livingstone N; Hanratty J; McShane R; Macdonald G
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011546. PubMed ID: 26513128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donepezil for mild cognitive impairment.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2006 Jul; (3):CD006104. PubMed ID: 16856114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinesterase inhibitors for rarer dementias associated with neurological conditions.
    Li Y; Hai S; Zhou Y; Dong BR
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009444. PubMed ID: 25734590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for preventing and ameliorating cognitive deficits in adults treated with cranial irradiation.
    Day J; Zienius K; Gehring K; Grosshans D; Taphoorn M; Grant R; Li J; Brown PD
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD011335. PubMed ID: 25519950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic treatment of depression in multiple sclerosis.
    Koch MW; Glazenborg A; Uyttenboogaart M; Mostert J; De Keyser J
    Cochrane Database Syst Rev; 2011 Feb; (2):CD007295. PubMed ID: 21328292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
    Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
    J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for chronic cognitive impairment in traumatic brain injury.
    Dougall D; Poole N; Agrawal N
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009221. PubMed ID: 26624881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab for relapsing-remitting multiple sclerosis.
    He D; Guo R; Zhang F; Zhang C; Dong S; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD009130. PubMed ID: 24310855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for relapsing-remitting multiple sclerosis.
    He D; Zhou H; Han W; Zhang S
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009130. PubMed ID: 22161445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivastigmine for vascular cognitive impairment.
    Birks J; McGuinness B; Craig D
    Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laquinimod for multiple sclerosis.
    He D; Han K; Gao X; Dong S; Chu L; Feng Z; Wu S
    Cochrane Database Syst Rev; 2013 Aug; (8):CD010475. PubMed ID: 23922214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory Rehabilitation for people with multiple sclerosis.
    das Nair R; Ferguson H; Stark DL; Lincoln NB
    Cochrane Database Syst Rev; 2012 Mar; (3):CD008754. PubMed ID: 22419337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
    Rodda J; Morgan S; Walker Z
    Int Psychogeriatr; 2009 Oct; 21(5):813-24. PubMed ID: 19538824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.